Literature DB >> 32940963

Impact of COVID-19 outbreak on rheumatic patients' perceptions and behaviors: A cross-sectional study.

Lena Mostafa Hassen1,2, Ibrahim A Almaghlouth1,3, Ikhlass Mostafa Hassen4, Maha H Daghestani2, Amal A Almohisen5, Eman M Alqurtas1, Abdulaziz Alkhalaf1, Mohammed K Bedaiwi1, Mohammed A Omair1, Sultan M Almogairen1, Hussein F Alarfaj1, Abdulrahman S Alarfaj1.   

Abstract

AIM: The dynamics of coronavirus disease 2019 (COVID-19) pandemic has become of special concern to the rheumatology community. Rheumatic patients are required to engage in effective health management but their behavior is often influenced by intrinsic and extrinsic factors. This cross-sectional study aims to examine patients' experiences during the current pandemic and its implication on their health perception and behavior.
METHOD: A patient-centered electronic survey was used, randomly sampling rheumatic patients in Saudi Arabia during March and April 2020. Questions included patients' socio-demographics, diseases, medications, COVID-19 knowledge, source of information, fear level, disease activity perception, health care utilization, medication accessibility, and therapeutic compliance (measured using a modified version of Medication Adherence Reporting Scale). Correlation and regression coefficients were used to evaluate associations among the aforementioned variables.
RESULTS: A total of 637 respondents were included. The majority were rheumatoid arthritis patients (42.7%). Patients' knowledge about COVID-19 was correlated with social media use (P = .012). Fear of COVID-19 infection correlated with healthcare facility for follow-up visits (P = .024) and fear of disease deterioration if contracting the infection correlated with patients' levels of knowledge (P = .035). Both types of fear did not correlate with patients' perceptions of disease activity. However, patients' perceptions of worsened disease activity were correlated with unplanned healthcare visits (P < .001), medication non-adherence, and difficulty accessing medication (P = .010 and .006, respectively).
CONCLUSION: The COVID-19 pandemic and surrounding public health measures could affect rheumatic patients' health management which might contribute to disease flare-up and subsequently taxing healthcare systems even further.
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  COVID-19 outbreak; disease activity perception; health care utilization; medication adherence; self-management

Year:  2020        PMID: 32940963     DOI: 10.1111/1756-185X.13959

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  14 in total

1.  Functional and psychosocial impact of COVID-19 pandemic on rheumatic patients' quality of life in Saudi Arabia.

Authors:  Lena M Hassen; Rana A Albarrak; Reem A Albahlal; Dimah K Alsaqabi; Ikhlass M Hassen; Maha H Daghestani; Eman M Alqurtas; Abdulaziz T Alkhalaf; Mohammed K Bedaiwi; Mohammed A Omair; Ibrahim A Almaghlouth
Journal:  Qual Life Res       Date:  2022-07-20       Impact factor: 3.440

Review 2.  Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

3.  National systemic lupus erythematosus prospective cohort in Saudi Arabia: A study protocol.

Authors:  Ibrahim A Almaghlouth; Lena M Hassen; Hana S Alahmari; Asma Bedaiwi; Rana Albarrak; Maha Daghestani; Eman Alqurtas; Abdulaziz Alkhalaf; Mohammed Bedaiwi; Mohammed Omair; Sultan Almogairen; Hussein Alarfaj; Abdulrahman Alarfaj
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

4.  Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.

Authors:  Gareth J Treharne; Grace Johnstone; Benjamin D Fletcher; Roisin S M Lamar; Douglas White; Simon Stebbings; Andrew Harrison
Journal:  Musculoskeletal Care       Date:  2021-08-13

5.  Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France).

Authors:  Baptiste Queré; Alain Saraux; Thierry Marhadour; Sandrine Jousse-Joulin; Divi Cornec; Camille Houssais; Guillermo Carvajal Alegria; Maxime Quiviger; Margot Le Guillou; Valérie Devauchelle-Pensec; Dewi Guellec
Journal:  Joint Bone Spine       Date:  2021-03-27       Impact factor: 4.929

Review 6.  Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.

Authors:  Bruno Silva Andrade; Sérgio Siqueira; Wagner Rodrigues de Assis Soares; Fernanda de Souza Rangel; Naiane Oliveira Santos; Andria Dos Santos Freitas; Priscila Ribeiro da Silveira; Sandeep Tiwari; Khalid J Alzahrani; Aristóteles Góes-Neto; Vasco Azevedo; Preetam Ghosh; Debmalya Barh
Journal:  Viruses       Date:  2021-04-18       Impact factor: 5.048

7.  Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America.

Authors:  Daniel G Fernández-Ávila; Julián Barahona-Correa; Diana Romero-Alvernia; Sergio Kowalski; Ana Sapag; Antonio Cachafeiro-Vilar; Belia Meléndez; Carlos Pastelín; Daniel Palleiro; Dina Arrieta; Gil Reyes; Guillermo J Pons-Estel; Jossiell Then-Báez; Manuel F Ugarte-Gil; Mario H Cardiel; Nelly Colman; Nilmo Chávez; Paula I Burgos; Rubén Montufar; Sayonara Sandino; Yurilis J Fuentes-Silva; Enrique R Soriano
Journal:  Rheumatol Int       Date:  2021-11-05       Impact factor: 2.631

8.  Coronavirus disease 2019 in patients with Behcet's disease: a report of 59 cases in Iran.

Authors:  Farhad Shahram; Kamal Esalatmanesh; Alireza Khabbazi; Zahra Rezaieyazdi; Zahra Mirfeizi; Alireza Sadeghi; Mohsen Soroosh; Hoda Kavosi; Majid Alikhani; Shayan Mostafaei
Journal:  Clin Rheumatol       Date:  2021-11-29       Impact factor: 3.650

9.  Exploring Factors Influencing Medication Compliance in Saudi Rheumatoid Arthritis Patients: A Nationwide Cross-Sectional Survey - Results from the COPARA Study.

Authors:  Mohammed A Omair; Maha M Alshehri; Nouf A Altokhais; Ghada A Aljanobi; Maha I El Dessougi; Amal AlHarthi; Maha A Omair; Suzan M Attar; Sami M Bahlas; Abdullah S Alfurayj; Mansour S Alazmi; Alhussain M Asiri; Mohammed M AlOmair; Lobna Al Juffali; Haya M Almalag
Journal:  Patient Prefer Adherence       Date:  2022-04-26       Impact factor: 2.711

10.  Rapid Review of Medication Taking (Adherence) Among Patients With Rheumatic Diseases During the COVID-19 Pandemic.

Authors:  Nevena Rebić; Jamie Y Park; Ria Garg; Ursula Ellis; Ayano Kelly; Eileen Davidson; Mary A De Vera
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-05       Impact factor: 5.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.